首页 正文

Review Cancer treatment reviews. 2015 Mar;41(3):235-46. doi: 10.1016/j.ctrv.2015.02.001 Q110.52025

Primary and secondary bone lymphomas

原发和继发骨淋巴瘤 翻译改进

Carlo Messina  1, David Christie  2, Emanuele Zucca  3, Mary Gospodarowicz  4, Andrés J M Ferreri  5

作者单位 +展开

作者单位

  • 1 Unit of Lymphoid Malignancies, Department of Onco-Haematology, San Raffaele Scientific Institute, Milan, Italy.
  • 2 Genesiscare and Bond University, Inland Dr., Tugun, QLD, Australia.
  • 3 Oncology Institute of Southern Switzerland, Bellinzona, Switzerland.
  • 4 Department of Radiation Oncology, Princess Margaret Hospital, Ontario Cancer Institute, Toronto, ON, Canada.
  • 5 Unit of Lymphoid Malignancies, Department of Onco-Haematology, San Raffaele Scientific Institute, Milan, Italy. Electronic address: andres.ferreri@hsr.it.
  • DOI: 10.1016/j.ctrv.2015.02.001 PMID: 25698636

    摘要 Ai翻译

    Recent studies have contributed to the enhancement of clinical and molecular knowledge on bone lymphomas, a group of rare malignancies with particular characteristics. Nevertheless, several questions remain unanswered and the level of evidence supporting some diagnostic and therapeutic decisions remains low. Currently, three different forms of bone lymphomas can be distinguished: the primary bone lymphoma, consisting of a single bone lesion with or without regional lymphadenopathies; the polyostotic lymphoma, consisting of multifocal disease exclusively involving the skeleton; and the disseminated lymphoma with secondary infiltration of the skeleton. The first two forms exhibit a good prognosis, requiring treatments similar to those commonly used for nodal lymphomas of the same category, but several issues regarding the role of surgery and local control of the disease, the sequence of treatment, radiation volumes and doses, management of pathological fractures and prevention of late sequelae deserve particular attention. Due to its rarity, prospective trials exclusively focused on bone lymphomas appear unrealistic, thus, critical revision of our own experience and analyses of large cumulative series as well as molecular studies on archival cases remain valid alternatives to improve our knowledge on this obscure lymphoproliferative malignancy. The present review is based on the analysis of the largest available database of bone lymphomas established under the sponsorship of the International Extranodal Lymphoma Study Group (IELSG) as well as on the critical revision of related literature. We provide recommendations for diagnosis, staging, treatment, and response assessment of these patients in everyday practice as well as for the management of special conditions like pathological fractures, indolent forms and central nervous system prophylaxis.

    Keywords: Diffuse large B-cell lymphoma; Extranodal lymphoma; Osteolymphoma; Polyostotic lymphoma; Primary bone lymphoma.

    Keywords:primary bone lymphomas; secondary bone lymphomas

    Copyright © Cancer treatment reviews. 中文内容为AI机器翻译,仅供参考!

    相关内容

    期刊名:Cancer treatment reviews

    缩写:CANCER TREAT REV

    ISSN:0305-7372

    e-ISSN:1532-1967

    IF/分区:10.5/Q1

    文章目录 更多期刊信息

    全文链接
    引文链接
    复制
    已复制!
    推荐内容
    Primary and secondary bone lymphomas